REGENERON PHARMACEUTICALS (REGN) Stock Institutional Owners


REGENERON PHARMACEUTICALS (REGN) is held by 7 institutional investors with a total value of $2.82B. This comprehensive analysis highlights the top institutional holders led by Dodge & Cox Stock Fund, Longleaf Partners, Sound Shore Management, and others, who collectively account for nearly 100% of the total institutional ownership.Dodge & Cox Stock Fund remains the largest institutional holder with a position worth $2.56B. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.

Explore more:

NameInvestor/ManagerPortfolio %QuantityReported Balance
Dodge & Cox Stock FundV. D. Dodge, E. M. Cox1.38%4,550,845$2,558,803,618
Longleaf PartnersMason Hawkins5.70%165,792$127,969,871
Sound Shore ManagementHarry Burn2.14%115,028$64,676,793
Parnassus Endeavor FundParnassus Investments0.13%101,023$56,802,202
Renaissance Technologies LLCJim Simons0.01%9,082$7,010,123
ARK InvestCathie Wood0.04%12,142$6,827,330
Sequoia Financial Advisors0.01%2,654$1,492,242

Frequently asked questions about REGN

  • Who owns the most REGN stock?

    The largest holders of REGN are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for REGENERON PHARMACEUTICALS (REGN).

  • Is REGN widely held by superinvestors?

    Many widely followed stocks like REGN appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly REGN is represented among the institutional managers we track.